Across TCGA pan-cancer cohorts, LINC01674 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated LINC01674 data layer.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC01674 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01674 expression acts as an unfavorable survival marker, although some lineages such as OV and GBM show a favorable association.
COAD, PCPG, and OV are the cancer types where LINC01674 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.